Last updated on March 2020

C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

Brief description of study

This is a non-interventional treatment Registry of Hereditary Angioedema (HAE) patients treated with C1 inhibitor, either plasma-derived (pdC1INH) or the recombinant human form (rhC1INH / Ruconest), to observe adverse events and insufficient efficacy, and to assess the immunological profile following single and repeated treatment with Ruconest.

Detailed Study Description

see below

Clinical Study Identifier: NCT01397864

Find a site near you

Start Over